eFFECTOR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 90.4%.

Top 25 shareholders own 23.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.48%	Sabby Management, LLC	352,084	€13.6k	0%	0.07%
4.1%	Abingworth LLP	192,884	€7.5k	0%	no data
2.4%	Altitude Life Science Ventures	113,054	€4.4k	0%	100.0%
1.6%	Pfizer Inc.	75,152	€2.9k	0%	no data
1.44%	Parallel Advisors, LLC	67,738	€2.6k	0%	no data
1.31%	UBS Asset Management AG	61,667	€2.4k	0%	no data
1.11%	Blackstone Inc.	52,343	€2.0k	0%	no data
0.74%	Stephen Worland	34,987	€1.4k	5.44%	no data
0.54%	Geode Capital Management, LLC	25,583	€991.2	13.2%	no data
0.53%	The Vanguard Group, Inc.	25,070	€971.3	-72.9%	no data
0.46%	Hudson River Trading LLC, Asset Management Arm	21,528	€834.1	0%	no data
0.4%	Jane Street Group, LLC, Asset Management Arm	18,669	€723.3	0%	no data
0.38%	Virtu Financial LLC, Asset Management Arm	18,021	€698.2	0%	no data
0.31%	Pfizer Venture Investments LLC	14,602	€565.7	0%	0.01%
0.24%	Two Sigma Investments, LP	11,115	€430.6	0%	no data
0.22%	Sea Otter Advisors LLC	10,557	€409.0	0%	no data
0.21%	Tower Research Capital Europe Limited	9,805	€379.9	539%	no data
0.15%	Christopher Ehrlich	7,136	€276.5	0%	no data
0.066%	Michael Byrnes	3,117	€120.8	80.2%	no data
0.026%	Brian Gallagher	1,200	€46.5	0%	no data
0.012%	Royal Bank of Canada, Banking & Securities Investments	546	€21.2	26.4%	no data
0.0077%	Caroline Loewy	361	€14.0	0%	no data
0.0077%	Elizabeth Bhatt	361	€14.0	0%	no data
0.0051%	Morgan Stanley, Investment Banking and Brokerage Investments	240	€9.3	-85.1%	no data
0.0021%	Barclays Bank PLC, Securities Investments	100	€3.9	0%	no data